Home
>
National Drug Code (NDC)
>
Imiquimod
Imiquimod - 52549-4145-6 - (Imiquimod)
Drug Information of Imiquimod
| Product NDC: | 52549-4145 |
| Proprietary Name: | Imiquimod |
| Non Proprietary Name: | Imiquimod |
| Active Ingredient(s): | 50 mg/g & nbsp; Imiquimod |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Imiquimod
| Product NDC: | 52549-4145 |
| Labeler Name: | Taro Pharmaceutical Industries Ltd. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA200173 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110415 |
Package Information of Imiquimod
| Package NDC: | 52549-4145-6 |
| Package Description: | 24 PACKET in 1 CARTON (52549-4145-6) > .25 g in 1 PACKET (52549-4145-8) |
NDC Information of Imiquimod
| NDC Code | 52549-4145-6 |
| Proprietary Name | Imiquimod |
| Package Description | 24 PACKET in 1 CARTON (52549-4145-6) > .25 g in 1 PACKET (52549-4145-8) |
| Product NDC | 52549-4145 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Imiquimod |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 20110415 |
| Marketing Category Name | ANDA |
| Labeler Name | Taro Pharmaceutical Industries Ltd. |
| Substance Name | IMIQUIMOD |
| Strength Number | 50 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Increased Cytokine Activity [PE],Increased Cytokine Production [PE],Interferon Inducers [MoA] |
